Literature DB >> 2064601

Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells.

L Churchill1, F H Chilton, D Proud.   

Abstract

The present study has examined the interaction of platelet-activating factor (PAF) with cultured guinea pig tracheal epithelial cells (GTE). PAF stimulated GTE to release endogenous arachidonic acid and metabolize it to prostaglandins E2 and F2 alpha (PGE2 and PGF2 alpha). Prostanoid production by GTE in response to PAF was dose-dependent (0.1-100 nM) and was maximal within 5 min. PGE2 and PGF2 alpha levels increased by 3.3 +/- 0.8 and 3.2 +/- 0.6 ng/10(6) cells respectively over basal levels in response to 100 nM-PAF. The ability of GTE to synthesize and/or catabolize PAF was also examined. GTE readily incorporated [3H]acetate into a product which migrated on t.l.c. with PAF. However, further characterization of this product suggested that label had not been incorporated into PAF, but rather that it was incorporated into another lipid product with chromatographic characteristics similar to those of PAF. In contrast, GTE readily metabolized PAF to inactive products. When [3H]PAF was incubated with GTE, 50% of the total [3H]PAF added was catabolized in approx. 15 min. The major route of catabolism of PAF by GTE was the deacetylation-reacylation pathway, which yielded 1-O-[3H]alkyl-2-acyl-sn-glycerophosphocholine. Determination of the nature of the long-chain acyl group incorporated into the sn-2 position of the newly synthesized products revealed that oleic and linoleic acids were the major fatty acids present. Taken together, these results suggest that respiratory epithelial cells respond to stimulation by PAF with enhanced production of PGE2 and PGF2 alpha, and also have the capacity to modulate inflammatory reactions in the airways by their ability to degrade this potent inflammatory mediator.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2064601      PMCID: PMC1151046          DOI: 10.1042/bj2760593

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Growth and differentiation of human nasal epithelial cells in culture. Serum-free, hormone-supplemented medium and proteoglycan synthesis.

Authors:  R Wu; J Yankaskas; E Cheng; M R Knowles; R Boucher
Journal:  Am Rev Respir Dis       Date:  1985-08

2.  Increased biosynthesis of platelet-activating factor in activated human eosinophils.

Authors:  T Lee; D J Lenihan; B Malone; L L Roddy; S I Wasserman
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

3.  Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.

Authors:  T M McIntyre; G A Zimmerman; K Satoh; S M Prescott
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

4.  The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.

Authors:  J Lefort; D Rotilio; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1984-07       Impact factor: 8.739

5.  Metabolism of platelet-activating factor in human platelets. Transacylase-mediated synthesis of 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine.

Authors:  R M Kramer; G M Patton; C R Pritzker; D Deykin
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

6.  Structure elucidation of platelet activating factor derived from human neutrophils.

Authors:  K L Clay; R C Murphy; J L Andres; J Lynch; P M Henson
Journal:  Biochem Biophys Res Commun       Date:  1984-06-29       Impact factor: 3.575

7.  Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.

Authors:  B W Robinson; T L McLemore; R G Crystal
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

8.  Selective generation of leukotriene B4 by tracheal epithelial cells from dogs.

Authors:  M J Holtzman; H Aizawa; J A Nadel; E J Goetzl
Journal:  Biochem Biophys Res Commun       Date:  1983-08-12       Impact factor: 3.575

9.  Airway responses to sequential challenges with platelet-activating factor and leukotriene D4 in rhesus monkeys.

Authors:  R Patterson; P R Bernstein; K E Harris; R D Krell
Journal:  J Lab Clin Med       Date:  1984-09

10.  Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product.

Authors:  B Malone; T Lee; F Snyder
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

View more
  2 in total

1.  Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells.

Authors:  L Churchill; B Friedman; R P Schleimer; D Proud
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

2.  Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells.

Authors:  J M Herbert
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.